The biologic activities of peptidoglycan in experimental Haemophilus influenzae meningitis

M Burroughs1, S Prasad, C Cabellos

  • 1Laboratory of Molecular Infectious Diseases, Rockefeller University, New York, NY 10021.

Insights

Gram-negative peptidoglycan from Haemophilus influenzae causes brain edema in meningitis. This component is more potent than the intact cell wall and contributes significantly to disease pathology.

Area of Science:

  • Microbiology
  • Immunology
  • Pathology

Background:

  • Gram-positive bacterial cell walls are known inflammatory agents.
  • The role of gram-negative peptidoglycan in disease pathogenesis remains largely uncharacterized.

Purpose of the Study:

  • To investigate the inflammatory potential of Haemophilus influenzae peptidoglycan in a rabbit meningitis model.
  • To compare the bioactivity of intact cell wall, purified peptidoglycan, and soluble subcomponents.

Main Methods:

  • Administration of Haemophilus influenzae cell wall, purified peptidoglycan, and subcomponents into rabbit cerebrospinal fluid (CSF).
  • Assessment of brain edema, CSF leukocytosis, and protein accumulation.
  • Evaluation of peptidoglycan from ampicillin-resistant versus sensitive strains.
  • Analysis of ampicillin-induced bacterial lysates with neutralized endotoxin.

Main Results:

  • Haemophilus peptidoglycan induced brain edema at concentrations as low as 0.1 µg/mL in CSF.
  • Leukocytosis and protein accumulation in CSF required higher concentrations (≥10.0 µg/mL).
  • Solubilized peptidoglycan was 10-fold more potent than intact cell wall; resistant strains showed twofold greater bioactivity.

Conclusions:

  • Peptidoglycan from gram-negative bacteria, specifically Haemophilus influenzae, contributes to the pathology of meningitis.
  • Peptidoglycan is a significant driver of brain edema in this condition.
  • The inflammatory effects are more pronounced with solubilized peptidoglycan and from antibiotic-resistant strains.

Related Concept Videos

Peptidoglycan Synthesis01:28

Peptidoglycan Synthesis

Structure of PeptidoglycanPeptidoglycan is a vital structural component of the bacterial cell wall, providing mechanical strength and shape to the cell. It consists of repeating units of two sugars—N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM)—linked by β-1,4 glycosidic bonds. These sugar chains are cross-linked by short peptide chains, forming a mesh-like polymer that surrounds the bacterial plasma membrane.Cytoplasmic Phase – Precursor SynthesisPeptidoglycan biosynthesis begins in...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...